Research from Penn State Clinical and Translational Science Institute on the societal costs of the opiod epidemic is featured in a more
A collaborative process between academic and non-profit researchers, including those from the North Carolina Translational and Clinical Sciences (NC TraCS) Institute at the University of North Carolina at Chapel Hill (UNC), and the North Carolina Department of Health and Human Services (DHHS) more
NIH leadership from across the agency has been working diligently over the past several months to identify areas of greatest opportunity for research to address the national opioid crisis. The result is more
What could be the first medical treatment for cocaine addiction is being created by Institute for Translational Medicine (ITM) researchers Ming Xu, PhD, and Xiaoyang Wu, PhD. Their research edits a patch of normal skin using an engineering technology that puts an anti-cocaine gene into skin stem more
The concepts of known knowns, known unknowns, and unknown unknowns apply not only to intelligence and politics, but to any discipline where the gathering of knowledge is paramount. An all-day, multi site workshop on the devastating opioid crisis was held to discuss these concepts. The event, more
On June 22, 2018 the Irving Institute for Clinical and Translational Research hosted a symposium to stimulate collaborations among researchers, industry partners and the community to advance new efforts to address the opioid crisis. More than more
Many research strategies related to the opioid crisis focus on increasing access to effective treatments for opioid use disorders, but it’s also vital to prevent addiction before it starts. The Michigan Opioid Prescribing Engagement Network (Michigan OPEN) more
Experts in many corners of Penn Medicine are at work combatting the deadly toll of the opioid epidemic, including the physicians and researchers of the Center for Health Incentives and Behavioral Economics (CHIBE) at the Perelman School of Medicine. As one more
Survivors of opioid overdose have a higher risk of death than individuals who have not experienced an overdose. Effective strategies to lower that risk are critically important to combatting the opioid epidemic in the United States.
Medications to treat opioid use disorder (OUD) are one more
On Saturday, June 2, over 100 researchers, doctors and public health professionals gathered at the University of Rochester Medical Center to discuss how to best address the opioid crisis through translational science and research. Attendees from more than 40 institutions, agencies and companies more
It’s one of the largest, most wide-spread public health crises our country and our community has ever faced. The incidence rate of heroin and prescription opioid abuse and related deaths has reached epidemic proportions. On today’s show, we’ll explore how this concerning problem is more
The Clinical & Translational Science Institute of Southeast Wisconsin (CTSI) is pleased to announce our Request for Applications for 2019 Traditional Pilot Awards as part of the Pilot Translational & Clinical Studies Program.
The total available funding CTSI is offering for the more
Patients taking a class of drug known to increase the risk for overdoses were likelier to receive a first-time opioid prescription than the general population, according to new research in JAMA Psychiatry from KL2 scholar John Mafi and colleagues. Patients taking a class of anti-anxiety more